Gilder Gagnon Howe & Co’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-160,515
| Closed | -$255K | – | 341 |
|
|
2023
Q1 | $255K | Sell |
160,515
-992
| -0.6% | -$1.58K | ﹤0.01% | 236 |
|
|
2022
Q4 | $236K | Sell |
161,507
-100
| -0.1% | -$146 | ﹤0.01% | 234 |
|
|
2022
Q3 | $690K | Sell |
161,607
-940
| -0.6% | -$4.01K | 0.01% | 212 |
|
|
2022
Q2 | $631K | Sell |
162,547
-19,849
| -11% | -$77.1K | 0.01% | 216 |
|
|
2022
Q1 | $868K | Sell |
182,396
-32,170
| -15% | -$153K | 0.01% | 256 |
|
|
2021
Q4 | $783K | Buy |
214,566
+63,216
| +42% | +$231K | ﹤0.01% | 305 |
|
|
2021
Q3 | $1.21M | Buy |
151,350
+476
| +0.3% | +$3.82K | 0.01% | 318 |
|
|
2021
Q2 | $1.71M | Buy |
+150,874
| New | +$1.71M | 0.01% | 309 |
|